Pieris Pharmaceuticals, Inc. (PIRS)
USD 13.6
(-15.58%)
USD 13.6
(-15.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 42.81 Million | 25.9 Million | 31.41 Million | 29.32 Million | 46.27 Million | 29.1 Million |
| Cost of Revenue | 41.8 Million | 2.78 Million | 2.36 Million | 46.53 Million | 54.99 Million | - |
| Gross Profit | 1 Million | 23.12 Million | 29.05 Million | -17.2 Million | -8.71 Million | 29.1 Million |
| Operating Expenses | 72.56 Million | 61.2 Million | 79.56 Million | 63.24 Million | 73.43 Million | 59.93 Million |
| Selling, General and Administrative Expenses | 16.85 Million | 16.39 Million | 16.59 Million | 16.71 Million | 18.44 Million | 18.44 Million |
| Research and Development Expenses | 41.8 Million | 52.98 Million | 66.65 Million | 46.53 Million | 54.99 Million | 41.49 Million |
| Other Expenses | - | -8.17 Million | -3.68 Million | -3.65 Million | -26 Thousand | 1.8 Million |
| Cost and Expenses | 72.56 Million | 61.2 Million | 79.56 Million | 63.24 Million | 73.43 Million | 59.93 Million |
| Operating Income | -29.75 Million | -43.47 Million | -51.83 Million | -33.92 Million | -27.15 Million | -30.83 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -2.02 Million | -2.37 Million | 164 Thousand | -1.71 Million | -312 Thousand |
| Earnings before Tax | -24.54 Million | -33.27 Million | -45.73 Million | -37.06 Million | -25.46 Million | -27.06 Million |
| Net Income | -24.54 Million | -31.25 Million | -43.36 Million | -37.23 Million | -23.75 Million | -26.75 Million |
| Earnings Per Share Basic | -21.80 | -33.71 | -53.75 | -54.67 | -37.54 | -40.32 |
| Earnings Per Share Diluted | -21.80 | -33.71 | -53.75 | -54.67 | -37.54 | -40.32 |
| Weighted Average Shares Outstanding | 1.12 Million | 927.15 Thousand | 806.83 Thousand | 681.01 Thousand | 632.81 Thousand | 663.51 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.12 Million | 927.15 Thousand | 806.83 Thousand | 681.01 Thousand | 632.81 Thousand | 663.51 Thousand |
| Gross Margin | 0.02 | 0.89 | 0.92 | -0.59 | -0.19 | 1.00 |
| EBIT Margin | -0.53 | -1.36 | -1.53 | -1.08 | -0.56 | -1.04 |
| Profit Margin | -0.57 | -1.21 | -1.38 | -1.27 | -0.51 | -0.92 |
| EBITDA | -22.76 Million | -30.49 Million | -43.37 Million | -31.61 Million | -26.11 Million | -30.26 Million |
| Earnings Before Tax Margin | -0.70 | -1.68 | -1.65 | -1.16 | -0.59 | -1.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 53 Thousand | 1.29 Million | 42.81 Million | 19.52 Million | 20.05 Million |
| Cost of Revenue | 751 Thousand | -30 Thousand | 4.45 Million | 1.78 Million | 739 Thousand | 725 Thousand |
| Gross Profit | -751 Thousand | 83 Thousand | -3.15 Million | 41.02 Million | 18.78 Million | 19.33 Million |
| Operating Expenses | 4.17 Million | 5.38 Million | 6.78 Million | 56.87 Million | 16.43 Million | 16.4 Million |
| Selling, General and Administrative Expenses | 3.42 Million | 4.13 Million | 2.32 Million | - | 6.83 Million | 3.66 Million |
| Research and Development Expenses | 751 Thousand | 1.24 Million | 4.45 Million | - | 9.59 Million | 14.32 Million |
| Other Expenses | 386 Thousand | 171 Thousand | 15.59 Million | 13.91 Million | 506 Thousand | -161 Thousand |
| Cost and Expenses | 4.17 Million | 5.35 Million | 6.78 Million | 58.65 Million | 16.43 Million | 16.4 Million |
| Operating Income | -4.17 Million | -5.3 Million | -5.48 Million | -15.84 Million | -11.8 Million | 2.06 Million |
| Interest Expense | - | - | 2.32 Million | - | - | - |
| Income Tax Expense | - | -73.27 Thousand | -699 Thousand | - | 14.34 Million | -490 Thousand |
| Earnings before Tax | -3.59 Million | -4.89 Million | -4.58 Million | -24.54 Million | -10.75 Million | 3.97 Million |
| Net Income | -3.59 Million | -4.89 Million | -4.58 Million | -24.54 Million | -10.75 Million | 3.97 Million |
| Earnings Per Share Basic | -2.76 | -3.95 | -3.71 | - | -8.70 | 3.63 |
| Earnings Per Share Diluted | -2.76 | -3.95 | -3.71 | - | -8.70 | 3.63 |
| Weighted Average Shares Outstanding | 1.29 Million | 1.23 Million | 1.23 Million | 1.12 Million | 1.23 Million | 1.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.29 Million | 1.23 Million | 1.23 Million | 1.12 Million | 1.23 Million | 1.09 Million |
| Gross Margin | - | 1.57 | -2.43 | 0.96 | 0.96 | 0.96 |
| EBIT Margin | - | -100.62 | -4.39 | - | 0.96 | 0.22 |
| Profit Margin | - | -92.30 | -3.53 | -0.57 | -0.55 | 0.20 |
| EBITDA | -4.17 Million | -5.33 Million | -5.7 Million | - | 18.68 Million | 4.37 Million |
| Earnings Before Tax Margin | - | -100.06 | -4.22 | -0.37 | -0.60 | 0.10 |
228670
GMPW
FFDF
JJFINCOR
ESHDF
CHNUF